Delivery Order SPE2DR25D2009-SPE2DR26FJ4Q2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,476.56 on December 15, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,518.18 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on December 12, 2025, with a completion date of December 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $24,148.65 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pens on November 18, 2025, with a completion date of November 19, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location and supports the military...
- The Defense Logistics Agency awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This delivery order is executed under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $36,921.15 by the Defense Logistics Agency (DLA) on November 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pens. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens with a ceiling value of $1,107.42. This is a firm fixed-price delivery order with no set-aside designation, requiring completion by December 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a single-unit pharmaceutical transaction under AmerisourceBergen's existing contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,205.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The order will be fulfilled from the...
- The Defense Logistics Agency awarded a $17,699.94 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Zepbound 10 mg/0.5 mL pens. The contract, classified as a firm fixed price delivery order with an ultimate completion date of December 17, 2025, represents a non-competitive set-aside award supporting the agency's pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ4Q2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,566.07 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pens on December 29, 2025, with an ultimate completion date of December 30, 2025. This firm fixed-price delivery order represents a procurement of pharmaceutical products to support federal medical supply needs. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's substantial contract portfolio with the Defense Logistics Agency demonstrates its critical role in the federal pharmaceutical supply chain, with consistent delivery orders for brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/28/25 |